Get started
Author

Linas Davainis

Observed names: Davainis, Linas, L Davainis, L. Davainis
OpenAlex ID: A5017935090
Venetoclax-based salvage therapy followed by Venetoclax and DLI maintenance vs. FLAG-Ida for relapsed or refractory acute myeloid leukemia after allogeneic stem cell transplantation
2021 · Andrius Zucenka, Vilmante Vaitekenaite, et al. · Bone Marrow Transplantation · 22
Outcomes of relapsed or refractory acute myeloid leukemia patients failing venetoclax‐based salvage therapies
2020 · Andrius Zucenka, Regina Pileckyte, et al. · European Journal Of Haematology · 17
Glasdegib in combination with low-dose Cytarabine for the outpatient treatment of relapsed or refractory acute myeloid leukemia in unfit patients
2021 · Andrius Zucenka, Kazimieras Maneikis, et al. · Annals of Hematology · 14
PDF
The Feasibility of Ibrexafungerp for the Treatment of Fungal Infections in Patients with Hematological Malignancies
2022 · Justinas Daraskevicius, Vidmantas Petraitis, et al. · Journal of Fungi · 10
PDF
Efficacy of Antiseptic Solutions in Treatment of Staphylococcus Aureus Infected Surgical Wounds with Patches of Vascular Graft: An Experimental Study in Rats
2019 · Elvyra Stanevičiūtė, Inga Urtė Builytė, et al. · Medicina · 7
PDF
Mesenchymal stromal cells for steroid-refractory biopsy-proven grade III-IV acute Graft-versus-Host Disease with predominant gastrointestinal involvement
2025 · Adomas Bukauskas, Renata Jucaitienė, et al. · Frontiers in Immunology · 5
PDF
Frontline Sequential Allogeneic Stem Cell Transplantation for Newly Diagnosed Acute Myeloid Leukemia with 3q26.2/Mecom Rearrangement
2024 · Andrius Žučenka, Lukas Kevličius, et al. · Blood · 2
Hypomethylating agents or chemotherapy in combination with venetoclax and gilteritinib for FLT3-mutated Acute Myeloid Leukemia
2025 · Andrius Zucenka, Milda Mikalonyte, et al. · Blood · 1
PDF
Individualized Sequential Allogeneic Stem Cell Transplantation for Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome Patients with Active Disease
2024 · Andrius Zucenka, Lukas Kevličius, et al. · Blood · 1
AML-998: Outcomes of Consolidative Allogeneic Transplantation After Venetoclax Plus Hypomethylating Agent Induction in Acute Myeloid Leukemia: A Single-Center Retrospective Study
2026 · Milvydė Tamutytė-Jankauskė, Milda Mikalonytė, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: AML-998: Outcomes of Consolidative Allogeneic Transplantation After Venetoclax Plus Hypomethylating Agent Induction in Acute Myeloid Leukemia: A Single-Center Retrospective Study
2026 · Milvydė Tamutytė-Jankauskė, Milda Mikalonytė, et al. · Clinical Lymphoma Myeloma & Leukemia
AML-783: Upfront Allogeneic Stem Cell Transplantation With Individualized Venetoclax-Based Conditioning in MECOM-Rearranged Acute Myeloid Leukemia: A Single-Center Retrospective Study
2026 · Milda Mikalonyte, Milvyde Tamutyte -Jankauske, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: AML-783: Upfront Allogeneic Stem Cell Transplantation With Individualized Venetoclax-Based Conditioning in MECOM-Rearranged Acute Myeloid Leukemia: A Single-Center Retrospective Study
2026 · Milda Mikalonytė, Milvydė Tamutytė-Jankauskė, et al. · Clinical Lymphoma Myeloma & Leukemia
Case Report: Alectinib and CNS-directed therapy for primary or relapsed ALK-positive anaplastic large cell lymphoma with central nervous system involvement
2026 · Milda Mikalonytė, Vilhelmas Landsbergis, et al. · Frontiers in Oncology
PDF
Pseudomonas aeruginosa meningitis following autologous hematopoietic stem cell transplantation
2026 · Linas Davainis, Agata Bruzgul · Research Square
PDF
Conditioning with alkylating agents, cytarabine, cladribine, hypomethylating agents, and venetoclax (ARCHIVE) for upfront allogeneic stem cell transplantation in patients with active Acute Myeloid Leukemia or myelodysplastic syndrome with increased blasts-2
2025 · Andrius Zucenka, Lukas Kevlicius, et al. · Blood
POSTER: MM-721 Selinexor-Based Therapy for Patients With Relapsed/Refractory Multiple Myeloma
2025 · Guoda Daukėlaitė, L Davainis, et al. · Clinical Lymphoma Myeloma & Leukemia
MM-721: Selinexor-Based Therapy for Patients With Relapsed/Refractory Multiple Myeloma
2025 · Guoda Daukelaite, L Davainis, et al. · Clinical Lymphoma Myeloma & Leukemia
783 | Place‐of‐care Produced Fresh Formulation Mb‐cart19.1 Cell Therapy for Relapsed or Refractory Cd19+ Hematological Malignancies With Central Nervous System Involvement
2025 · S. Cernauskiene, A. Bukauskas, et al. · Hematological Oncology
PDF
AML-672 Venetoclax-Based Preconditioning Followed by Immediate Allogeneic Stem Cell Transplantation (alloSCT) for Relapsed or Refractory Acute Myeloid Leukemia (R/R AML) or High-Risk Myelodysplastic Syndromes (HR-MDS)
2024 · Lukas Kevlčius, Tautvilė Smalinskaitė, et al. · Clinical Lymphoma Myeloma & Leukemia
Venetoclax-Based Preconditioning Followed by Immediate Allogeneic Stem Cell Transplantation (alloSCT) for Relapsed or Refractory Acute Myeloid Leukemia (R/R AML) or High-Risk Myelodysplastic Syndromes (HR-MDS)
2024 · Lukas Kevličius, Tautvilė Smalinskaitė, et al. · Clinical Lymphoma Myeloma & Leukemia
Real-World Comparison of Venetoclax-Based Treatment Versus Intensive Chemotherapy As Bridging to Allogeneic Stem Cell Transplantation in MDS-IB2 Patients
2023 · Andrius Zucenka, Birutė Davainienė, et al. · Blood
A Severe Case of Invasive Rhino-Orbito-Cerebral Mucormycosis in a Patient with Acute T-Cell Leukemia with Successful Outcome: a Case Report and a Literature Review
2023 · Linas Davainis, Dominyka Vasilevska, et al. · Archives of Clinical and Medical Case Reports
Venetoclax-Based Therapies for Acute Myeloid Leukemia or Myelodysplastic Syndrome with Excess Blasts-2 in Clinical Practice Setting
2022 · Andrius Žucenka, Lukas Kevličius, et al. · Blood
Works count: 26
Citation count: 79
H-index: 5
I10-index: 4
Year
Topic
Type